Lancet (London, England)
BCMA-CD3 T-cell engager as salvage therapy for multirefractory primary immune thrombocytopenia.
Jesus Duque-Afonso, Christoph Rummelt, Katharina Förster, Robert Zeiser, Dimitrios Mougiakakos
Published: 202610.1016/S0140-6736(25)02515-2
No abstract available for this study.